Methotrexate
ADVERTISEMENT
- Molecular formula
- C20H22N8O5
- CAS Number
- 59-05-2
- IUPAC Name
- 2-[[4-(3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H-imidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioic acid
- Molecular Weight
- 454.44g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.4100g/cm3
Identification
Interesting facts
Interesting Facts About 2-[[4-(3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H-imidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioic acid
This compound represents a fascinating intersection of organic chemistry and medicinal applications. It exhibits properties that could be leveraged in biochemistry and pharmacology. Here are some noteworthy elements regarding this compound:
- Diverse Structure: The presence of an imidazo[1,5-f]pteridin moiety suggests potential interactions with biological targets, particularly in nucleic acid binding and enzyme inhibition systems.
- Amino Acid Composition: The amino functionalities in the molecule may contribute to its bioactivity, mimicking natural amino acid interactions within biological systems.
- Potential Antitumor Activity: Research indicates that similar compounds have been studied for their *antitumor* effects. Understanding the mechanism of action may lead to new cancer therapies.
- Complexity and Synthesis: The synthetic pathway to create this compound is remarkable and may involve multiple steps, including the formation of various functional groups which can complicate purification.
- Future Research: Scientists are continually exploring this class of compounds for new pharmaceutical applications, especially in developing treatments for diseases where current modalities are ineffective.
In summary, 2-[[4-(3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H-imidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioic acid serves as a model for innovation in pharmaceutical chemistry. Its rich structural features present both challenges and opportunities in drug development.